16 September 2020 | Drug repositioning and repurposing for Alzheimer disease | Ballard, C; Aarsland, D; Cummings, J; et al. |
23 December 2020 | The accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies | Roberts, G; Donaghy, PC; Lloyd, J; et al. |
18 November 2019 | Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: A randomized clinical trial | Howard, R; Zubko, O; Bradley, R; et al. |
20 October 2021 | Neuropsychological Impairments and their cognitive architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer’s Disease | Ciafone, J; Thomas, A; Durcan, R; et al. |
22 September 2020 | Introduction of a management toolkit for Lewy body dementia: A pilot cluster randomised trial | O'Brien, JT; McKeith, IG; Thomas, AJ; et al. |
27 March 2021 | Utility of the pareidolia test in mild cognitive impairment with Lewy bodies and Alzheimer’s disease | Hamilton, CA; Matthews, FE; Allan, LM; et al. |
21 October 2020 | Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling | Firbank, MJ; O'Brien, JT; Durcan, R; et al. |
25 August 2020 | Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile | Donaghy, PC; Ciafone, J; Durcan, R; et al. |
28 July 2021 | Improving the diagnosis and management of Lewy body dementia: the DIAMOND-Lewy research programme including pilot cluster RCT | O'Brien, JT; Taylor, J-P; Thomas, A; et al. |
27 March 2021 | Hippocampal and Insula volume in mild cognitive impairment with Lewy bodies | Firbank, MJ; Durcan, R; O'Brien, JT; et al. |